EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer

Yukinori Okada, Tatsuhiko Zama, Tomohiro Itonaga, Ryuji Mikami, Mitsuru Okubo, Shinji Sugahara, Shiho Wada, Tsubasa Kawamoto, Yui Mabuchi, Masumi Kawaguchi, Masanori Ishida, Motoki Nakai und 3 weitere

Cancer Diagnosis & Prognosis · 01.07.2026 · 6 (4) · 608-618

DOI: 10.21873/cdp.10561 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.07.2026. Verfasst von Yukinori Okada und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tokyo Medical University, Tokyo, Japan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: In small-cell lung cancer, treatment differs between extensive disease (ED) and limited disease (LD). Chemotherapy plus immune checkpoint inhibitors is used in patients with ED. In patients with LD, chemoradiotherapy or chemoradiotherapy plus immune checkpoint inhibitors is used. Therefore, initial staging is important. Some reports exist on the utility of positron emission tomography-computed tomography (PET/CT); in particular, PET/CT can change the diagnosis between LD and ED. This review aimed to summarize the utility of PET/CT in small-cell lung cancer. Materials and Methods: We identified relevant articles published on PUBMED between 2010 and 2025 using selected keywords. We categorized the contents into disease staging, prognosis prediction, and topics, and then summarized section-by-section.

Results

In addition to cancer staging between ED and LD, PET/CT can be used to evaluate semiquantitative indicators such as the maximum standard uptake value (SUVmax), total lesion glycolysis (TLG), and metabolic tumor volume (MTV). This is important as SUVmax, TLG, and MTV have been shown to predict treatment response.

Conclusion

PET/CT is useful for staging small-cell lung cancers. However, reports on its usefulness for prognostic prediction are mixed, with some finding it useful and others not. Further research is needed as treatment approaches for small-cell lung cancer are evolving.

Schlagwörter

Stichwörter der Autor:innen

Small-cell lung cancermaximum standardized uptake valuemetabolic tumor volumepositron emission tomography-computed tomography imagingreviewtotal lesion glycolysis

Autor:innen und Institutionen

  • Department of Radiology, Tokyo Medical University, Tokyo, Japan.

Zitieren

APA

Okada, Y., Zama, T., Itonaga, T., Mikami, R., Okubo, M., Sugahara, S., Wada, S., Kawamoto, T., Mabuchi, Y., Kawaguchi, M., Ishida, M., Nakai, M., Abe, K., Yoshimura, M., & Saito, K. (2026). Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer. Cancer Diagnosis & Prognosis, 6(4), 608-618. https://doi.org/10.21873/cdp.10561

Vancouver

Okada Y, Zama T, Itonaga T, Mikami R, Okubo M, Sugahara S, et al. Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer. Cancer Diagnosis & Prognosis. 2026;6(4):608-618. doi:10.21873/cdp.10561

BibTeX
@article{Okada2026,
  author = {Okada, Yukinori and Zama, Tatsuhiko and Itonaga, Tomohiro and Mikami, Ryuji and Okubo, Mitsuru and Sugahara, Shinji and Wada, Shiho and Kawamoto, Tsubasa and Mabuchi, Yui and Kawaguchi, Masumi and Ishida, Masanori and Nakai, Motoki and Abe, Koichiro and Yoshimura, Mana and Saito, Kazuhiro},
  title = {Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer},
  journal = {Cancer Diagnosis & Prognosis},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {608--618},
  doi = {10.21873/cdp.10561}
}
Kostenlos starten →